SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Segment Reporting Information [Line Items]
Revenue	$ 4,470,875	$ 21,115,899
Cost of Sales	(3,221,915)	(12,782,624)
Gross Margin	1,248,960	8,333,275
Operating Expenses	(16,399,543)	(12,450,351)
Operating Income (Loss)	(15,150,583)	(4,117,076)
Other Income (Expense)	(33,767,897)	102,046
Net Income (Loss) Before Income Tax	(48,918,480)	(4,015,030)
Real Estate Segment[Member]
Segment Reporting Information [Line Items]
Revenue	2,829,270	19,608,184
Cost of Sales	(2,580,462)	(12,034,348)
Gross Margin	248,808	7,573,836
Operating Expenses	(3,467,772)	(1,793,188)
Operating Income (Loss)	(3,218,964)	5,780,648
Other Income (Expense)	(1,754,852)	1,522
Net Income (Loss) Before Income Tax	(4,973,816)	5,782,170
Digital Transformation Technology [Member]
Segment Reporting Information [Line Items]
Revenue	172
Cost of Sales	(247)
Gross Margin	(75)
Operating Expenses	(590,995)	(616,403)
Operating Income (Loss)	(591,070)	(616,403)
Other Income (Expense)	(2,050,303)	(2,947,968)
Net Income (Loss) Before Income Tax	(2,641,373)	(3,564,371)
Biohealth Business [Member]
Segment Reporting Information [Line Items]
Revenue
Cost of Sales		(3,370)
Gross Margin		(3,370)
Operating Expenses	(1,366,561)	(1,076,095)
Operating Income (Loss)	(1,366,561)	(1,079,465)
Other Income (Expense)	(669,113)	(139,737)
Net Income (Loss) Before Income Tax	(2,035,674)	(1,219,202)
Other [Member]
Segment Reporting Information [Line Items]
Revenue	1,641,433	1,507,715
Cost of Sales	(641,206)	(744,906)
Gross Margin	1,000,227	762,809
Operating Expenses	(10,974,215)	(8,964,666)
Operating Income (Loss)	(9,973,988)	(8,201,857)
Other Income (Expense)	(29,293,629)	3,188,229
Net Income (Loss) Before Income Tax	$ (39,267,617)	$ (5,013,628)